SCHEMBL4016473

SCHEMBL4016473

NC1CCN(c2ncnc3cc(Cl)ccc23)CC1.O=C(NC1CCN(c2ncnc3cc(Cl)ccc23)CC1)c1cccc(Cl)c1Cl

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PAK1 Q13153 7/20 0.65
SUV39H1 O43463 2/20 0.54
PRMT1 Q99873 2/20 0.54
SMYD3 Q9H7B4 2/20 0.54
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
P2RX7 Q99572 1/20 0.48
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
CNR1 P21554 3/20 0.45
CNR2 P34972 2/20 0.45
STK4 Q13043 1/20 0.43
STK3 Q13188 1/20 0.43
LRRK2 Q5S007 1/20 0.43
MAP3K5 Q99683 2/20 0.42
MAP3K6 O95382 1/20 0.42
KIT P10721 1/20 0.42
PDGFRB P09619 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4024568 0.95 PAK1 (0.68) PAK1SUV39H1PRMT1SMYD3CYP1A2
SCHEMBL4581895 0.88 PAK1 (0.68) PAK1CYP1A2CYP2D6P2RX7MEN1
SCHEMBL4024856 0.88 PAK1 (0.67) PAK1SUV39H1PRMT1SMYD3CYP1A2
SCHEMBL4557267 0.87 ALDH1A1 (0.54) PAK1P2RX7MEN1KMT2A
SCHEMBL4025750 0.86 PAK1 (0.66) PAK1SUV39H1PRMT1SMYD3CYP1A2
SCHEMBL4020785 0.86 PAK1 (0.66) PAK1SUV39H1PRMT1SMYD3CYP1A2
SCHEMBL4024042 0.85 PAK1 (0.71) PAK1P2RX7MEN1KMT2ACNR1
SCHEMBL4016410 0.85 PAK1 (0.64) PAK1SUV39H1PRMT1SMYD3CYP1A2
SCHEMBL4017800 0.84 PAK1 (0.55) PAK1SUV39H1PRMT1SMYD3CYP1A2
SCHEMBL4016414 0.84 PAK1 (0.63) PAK1SUV39H1PRMT1SMYD3P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2066654-A1 N-(1-HETARYLPIPERIDIN-4-YL)(HET)ARYLAMIDES AS EP2 RECEPTOR MODULATORS Bayer Schering Pharma AG (DE) 2009-06-10 EP claimed
WO-2008028691-A1 N-(1-HETARYLPIPERIDIN-4-YL)(HET)ARYLAMIDES AS EP2 RECEPTOR MODULATORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-03-13 WO claimed